P16410 (CTLA4_HUMAN) Homo sapiens (Human)
Cytotoxic T-lymphocyte protein 4 UniProtKBInterProSTRINGInteractive Modelling
223 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5);
4 identical sequences: Pan troglodytes: A0A6D2W8G9, A0A2I3SUF9; Pan paniscus: A0A2R9CI29; Gorilla gorilla gorilla: G3QY54
Available Structures
21 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Engineered Human Lipocalin 2 (LCN2) in Complex with the Extracellular Domain of Human CTLA-4 |
Heteromer | 100 | ||||
| Crystal structure of anti-CTLA-4 humanized IgG1 MAb--JS007 in complex with human CTLA-4 |
Heteromer | 100.0 | ||||
| CTLA-4 in complex with tremelimumab Fab |
Heteromer | 100 | ||||
| HUMAN B7-1/CTLA-4 CO-STIMULATORY COMPLEX |
Heteromer P33681; | 99.15 | 9×NAG; 1×MAN; | |||
| CRYSTAL STRUCTURE OF THE CTLA-4/B7-2 COMPLEX |
Heteromer P42081; | 100 | ||||
| A Non-blocking anti-CTLA-4 Nanobody complexed with CTLA-4 |
Heteromer | 100 | 2×NAG; 1×NAG; 1×NA; | |||
| The crystal structure of CTLA-4 and Fab |
Heteromer | 100.0 | ||||
| Crystal structure of anti-CTLA-4 VH domain in complex with human CTLA-4 |
Heteromer | 100.0 | 1×EDO; | |||
| Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.105 in complex with CTLA-4 |
Heteromer | 100 | 2×NAG; | |||
| Crystal structure of CTLA-4 complexed with the Fab of HL32 antibody |
Heteromer | 100 | 1×NAG; | |||
| A blocking anti-CTLA-4 Nanobody (KN044) complexed with CTLA-4 |
Heteromer | 100.0 | ||||
| Structure of the first-in-class checkpoint inhibitor Ipilimumab bound to human CTLA-4 |
Heteromer | 100.0 | ||||
| Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.106 in complex with CTLA-4 |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal Structure of Ipilimumab Fab complexed with CTLA-4 at 2.6A resolution |
Heteromer | 100.0 | ||||
| Crystal structure of CTLA-4 in complex with a high affinity CTLA-4 binder |
Heteromer | 100 | ||||
| MU2 ADAPTIN SUBUNIT (AP50) OF AP2 ADAPTOR (SECOND DOMAIN), COMPLEXED WITH CTLA-4 INTERNALIZATION PE… |
Heteromer Q96CW1; | 100 | ||||
| Molecular interactions of cytoplasmic region of CTLA-4 with SH2 domains of PI3-kinase |
Heteromer P27986; | 100 | ||||
| Crystal structure of human CTLA-4 apo homodimer | homo-2-mer | 100 | 2×NAG; 2×GOL; | |||
| Structure of a strand-swapped dimeric form of CTLA-4 | homo-2-mer | 100 | ||||
| CTLA-4, NMR, 20 STRUCTURES | monomer | 100 | 1×NAG; 1×NAG; | |||
| Complex structure of ipilimumab-scFv and CTLA-4 | monomer | 100.0 | ||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3osk.1.B | monomer | 0.79 | 100.00 | |||
| 2x44.1.A | monomer | 0.70 | 97.66 | |||
2 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 5 | 7elx.1.C | monomer | 0.81 | 94.44 | |||
| Isoform 5 | 2x44.1.A | monomer | 0.72 | 92.97 | |||